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ABSTRACT: Purpose: Insulin and glucose pathways play a key role to fetal viability and growth. The focus of the study is to 
investigate the potential differences of immunohistochemical expression of IR in trophoblastic and decidual cells between 
women who had recurrent pregnancy loss and women that underwent an abortion. Materials and methods: Trophoblastic and 
decidual tissues from fifty (50) women with elective abortion used as control group and from fifty (50) women with recurrent 
miscarriages were collected during gestational weeks 6 to 12. IR antibodies were used as immunohistochemical staining markers. 
Nuclear and cytoplasmic expression was evaluated. Results: No IR immunohistochemical expression was detected in both 
trophoblastic cells of the implantation site and deciduas basalis of the two study groups. Conclusion: The effort made to enhance 
our knowledge on the physiology and histology of IR expression in connection with pregnancy was halted because the results 
were inconclusive. While studying, though, the correlation of recurrent miscarriage with IR expression, it became evident that a 
lot of hormones and pathways form the weave of gestational pathology and its delicate harmony. Every piece of knowledge may 
clarify this still obscure field.  
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INTRODUCTION 
 
The beta cells of pancreas that belong to the endocrine 
component of pancreas, secret insulin, the key hormone in 
the regulation of intracellular and blood glucose 
interchange1,2,3,4. During gestation, insulin and its receptor 
participate in placental endocrine regulation and fetal 
vitality3,14. Adding to its endocrine control, human placenta 
has multiple functions, including response to various fetal 
or maternal molecules2,5,6. This reaction is heavily 
dependent to insulin receptor (IR) availability and binding 
properties. 
IR is a transmembrane tyrosine kinase receptor binding 
insulin, IGF-1 and IGF-2 and its activated form, encourages 
glucose uptake2. IR has two isoforms, IR-α and IR-β, 
encoded in one gene7. When insulin binds IR, glucose 
transporters are transferred to the membrane, so they are 
accessible to glucose. The part of the receptor that contains 
IR-α can be found mainly outside the cell and consists the 
binding component of the receptor15. Once activated by 
binding, the receptor is autophosphorylazed and thus 
bringing about the phosphorylazation of insulin receptor 
substrates, that helps manage the insulin intake through 
negative feedback (PI3-K)2. Activation of IR differentiates 
in effect depending in its location on deciduas basalis. In 
trophoblastic cells, it mainly stimulates cell proliferation 
and in the endothelium, it induces metabolic changes due to 
the activation of protein kinase B/Akt pathway5. 
All placental cells express insulin receptors, with varied 
densities among different tissues and throughout 
pregnancy2,5,10,11,12,13,14.  
 
MATERIALS AND METHODS 
 
The study group was obtained from 50 women who 
miscarried between the ages of 20-47 years and during 
gestational weeks 6-12. Controls consisted of 50 healthy 
women between the ages 27-39 years, who had electively 
terminated their pregnancies during gestational weeks 6-12. 
The gestational age was calculated from the last normal 
period to the date of curettage. 
Tissues were collected immediately after miscarriage or 
elective abortion and washed with distilled water. Then, 
they were studied under a microscope, so that specimens 
from decidua, villus chorion and parts of the embryo could 
be examined for formation abnormalities or placental 
lesions and excluded from the study.  
Afterwards, specimens were stabilized in aqueous solution 
of neutral formalin 10% v/v for 12-24 hours and then 
placed in an automatic machine for further processing, 
including fixation, dehydration, xylene clarification and 
paraffin embedding. Then, paraffin-embedded blocks of 
specimens were cut in 3 mm sections, covered with tape 
and transferred to positive charged and properly prepared 
glass plates, which were kept in an oven, at 37- 40°C for 30 
- 45 min. After this step, specimens were stained with 
haematoxylin- eosin solution (Harris) and examined with a 
microscope. The most suitable of them were gathered for 
immunohistochemical study.  
 
Immunohistochemistry  
 
In all specimens, decidua basalis was identified using the 
antibody cytokeratin (CK7), which is positive in 
trophoblastic cells. Furthermore, for discrimination between 
decidual and trophoblastic cells at the feto-maternal 
interface, duplicate sections were stained with a 
monoclonal antibody against prolactin, for the visualization 
of decidual cells. The unstained specimens were further 
processed using an automatic machine (Bond Max).  
For the detection of immunohistochemical staining, 
specimens were firstly immersed in Post-Primary solution. 
After being washed, specimens were immersed in Polymere 
solution and then in chromogen diaminobenzidine (DAB) 
solution. Finally, specimens were stained with 
Haematoxylin- Eosin. Following the previous stages that 
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were performed by the automatic processor, specimens 
were rinsed in tap water and dehydrated with escalating 
densities of ethanol solution (70, 96 and 100% v/v 
consecutively) and xylene.  
Then, they were covered with tape, placed in glass plates 
and immersed in Canada balsam 
Microscopic evaluation was conducted on the cells of the 
intermediate trophoblast on decidua basalis and decidua 
parietalis of recurrent miscarriage and elective abortion 
material. Specimens were examined using an optical Zeiss 
TM microscope and photographs were taken using a 
Contax TM camera, attached to the microscope. In total, 
100 specimens (50 from decidua basalis and 50 from 
decidua parietalis) were examined. Intensity of staining was 
evaluated as negative (-). 
 
RESULTS 
 
In trophoblastic cells of the implantation site the intensity 
of staining for IR immunohistochemical expression was 
negative to very lightly positive in both study groups. 
In deciduas basalis cells, the intensity of staining for IR 
immunohistochemical expression was negative, in both 
study groups ( Fig. 1-8) 
 
DISCUSSION 
 
The conception and maintenance of life throughout 
gestation has been the subject and focus of many studies for 
most of medical history. In the last decade, the role of 
hormones and hormonal receptors has been recognized as 
key for fetal survival and growth, but has yet to be fully 
outlined. In this study, an attempt was made in order to 
clarify if there is any correlation of the expression of insulin 
receptors (IR) with recurrent abortions. The result that 
pertain this particular interconnection is indecisive.  
According to Desoye G et al5, the levels of IR in different 
sites vary depending on the phase of gestation. Specifically, 
IR is elevated in synctytiotrophoblast, especially in 
syncytial sprouts and mesenchymal villi during the first 
trimester and has a higher affinity to insulin, and its levels 
and affinity slowly decline, resulting in sparse staining in 
term placentae12,16,10. Furthermore, the cytotrophoblast 
displays a dense expression of IR with a weaker one in 
microvilli that guides us to the following conclusion: 
insulin receptor is expressed whenever and wherever the 
need for growth arises11, 13. 
Let’s not forget that the IR and type 1 insulin-like growth 
factor (IGF) receptor are co-regulated by the same gene. A 
study has shown that hybrid receptors with a variety of 
structures and diverse affinity for both hormones have been 
detected. This fact indicates that we could have a distorted 
view of hormonal selectivity and research on the subject 
may yet alter the known physiological pathways for both17.  
In our current study, the clinical aspect has not been 
considered. But, there are a lot of disorders that change 
both the IR expression and the outcome of gestation. The 
most prominent of these are Diabetes Mellitus (DM) and 
gestational diabetes mellitus (GDM). It is known that 
women with untreated or unsuccessfully treated DM type 1 
in the first trimester have higher chances of fetal loss or 
neonatal complications, but the IR expression in these cases 
has not been widely studied18. 
As for GDM, according to studies contacted, the results 
vary, as one study shows a decrease of IR in placenta that 
was attributed to a negative feedback caused by high serum 
insulin levels19 and another, more recent, presents an 
elevation of IR and other components associated with 
insulin signal transduction20. A third study is more specific. 
It compares a healthy-control group of pregnant patients to 
a group of GDM patients treated solely by diet and to 
another treated with insulin and it shows that the second 
group has elevated IR expression while the third has 
decreased compared to the control group21. Also, there 
seems to be a fluctuating expression of IR substrates, IR 
types and proteins that participate in insulin signaling, 
between pregnant women with obesity and variably treated 
diabetes2. Comparing villous and extravillous trophoblast in 
the first trimester of pregnancy between normal, terminated 
pregnancies and pregnancies complicated by either 
hydatidiform mole or miscarriage, there is definite 
elevation of IR expression in the latter two categories14. As 
for gestation complicated by preeclampsia, the expression 
is not altered, but the binding capacity of IR tends to 
decrease collated to a healthy control group22.  
Except from miscarriage, there can be other adverse effects 
of altered IR expression on the outcome of a gestation. In 
placentas taken from IUGR fetuses show an altered 
expression of IR substrates and an increased of activated IR 
when contrasted with placentas taken from AGA fetuses23, 
24. Also, various studies have shown the effect that serum 
insulin and other hormones have on both IR expression and 
sustainability of gestation23, 24. 
It is quite apparent that there are a lot of factors and a lot of 
pathways that should be taken into account when 
investigating the interaction of IR expression with recurrent 
miscarriage, and a lot to be discovered still in the future, as 
our field of vision expands along with the development of 
technology.  
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Fig 1. Conrtol group. 
Immunohistochemical staining of IR 
in deciduas basalis. X16 
 
Fig 2. Conrtol group. 
Immunohistochemical staining of IR in 
deciduas basalis. X40 
 
Fig 3. Conrtol group. 
Immunohistochemical staining of IR 
in deciduas basalis. X160 
 
Fig 4. Conrtol group. 
Immunohistochemical staining of IR 
in implantation site. X40 
 
Fig 5. Conrtol group. 
Immunohistochemical staining of IR in 
implantation site X160 
 
Fig 6. Miscarriage group. . 
Immunohistochemical staining of IR 
in deciduas basalis.4X16 
 
Fig 7. Miscarriage group. 
Immunohistochemical staining of IR 
in deciduas basalis. X40 
 
Fig 8. Miscarriage group. 
Immunohistochemical staining of IR in 
implantation site. X16 
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H ανοσοϊστοχημική έκφραση του υποδοχέα της ινσουλίνης σε υλικά 
καθ’έξιν αποβολών. 
 
Παπαμήτσου Θεοδώρα, Γραμματικοπούλου Δανάη, Παπαδοπούλου Κυριακή, Καραχρυσάφη Σοφία, Τόσκας Αλέξανδρος, 
Χατζησταματίου Μαρία, Σιόγκα Αντωνία, Οικονόμου Λουΐζα. 
 
Εργαστήριο Ιστολογίας – Εμβρυολογίας, Ιατρική σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης 
 
Περίληψη: Σκοπός: Η διερεύνηση των πιθανών διαφορών στην ανοσοϊστοχημική έκφραση του υποδοχέα της ινσουλίνης (IR) 
σε τροφοβλαστικά κύτταρα στη θέση εμφύτευσης του εμβρύου καθώς και σε κύτταρα φθαρτού, μεταξύ των γυναικών που είχαν 
επαναλαμβανόμενες αποβολές και των γυναικών που υποβλήθηκαν σε άμβλωση. Υλικά και μέθοδος: Δείγματα ιστού από 
τροφοβλάστη και φθαρτό από 50 γυναίκες με εκλεκτική άμβλωση (ομάδα ελέγχου) και από 50 γυναίκες με επαναλαμβανόμενες 
αποβολές συλλέχθηκαν κατά την 6η έως 12η  εβδομάδα κύησης. Χρησιμοποιήθηκαν αντισώματα έναντι του IR και εκτιμήθηκε η 
ένταση της ανοσοϊστοχημικής χρώσης. Αποτελέσματα: Δεν ανιχνεύθηκε ανοσοϊστοχημική έκφραση του IR ούτε σε 
τροφοβλαστικά κύτταρα της θέσης εμφύτευσης ούτε σε κύτταρα φθαρτού, σε αμφότερες τις ομάδες μελέτης. Συμπέρασμα: Η 
προσπάθεια διαλεύκανσης του ρόλου του IR στην εγκυμοσύνη δεν ήταν εφικτή επειδή τα αποτελέσματα ήταν αμφιλεγόμενα. 
Ωστόσο, μελετώντας την πιθανή συσχέτιση των καθ’έξιν αποβολών με την έκφραση του IR, έγινε προφανές ότι πολλαπλοί 
μηχανισμοί, ανεξερεύνητοι σε μεγάλο βαθμό ακόμη, σχετίζονται με την παθολογία της εγκυμοσύνης 
 
Λέξεις κλειδιά:Υποδοχείς ινσουλίνης, καθ’ έξιν αποβολές 
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